NCT07154251

Brief Summary

This study uses community health workers (CHW) as diabetes technology coaches for African American children using automated insulin delivery systems but have an HbA1c of 8% or higher. Families will meet with the CHW monthly x 6 months with additional visits as needed. All participants and parents/guardians will fill out questionnaires at the beginning and end of the 6 month intervention in addition to an interview at 6 months. This will be followed by 6 months with no extra help from the CHW, but we will continue to follow CGM and pump download data.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
10mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress38%
Nov 2025Mar 2027

First Submitted

Initial submission to the registry

August 26, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 4, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

November 6, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

December 4, 2025

Status Verified

November 1, 2025

Enrollment Period

1.3 years

First QC Date

August 26, 2025

Last Update Submit

December 2, 2025

Conditions

Keywords

Automated insulin deliveryCommunity Health WorkerDisparitiesType 1 Diabetes

Outcome Measures

Primary Outcomes (2)

  • Change in capillary HbA1c

    Baseline, 3 months, 6 months, 9 months, 12 months

  • Change in number of participants who use an automated insulin delivery system with at least 80% time in automated mode over the past 30 days, as measured by download of data from the automated insulin delivery system

    Baseline, 3 months, 6 months, 9 months, 12 months

Secondary Outcomes (18)

  • Change in time in range (70-180 mg/dL) as measured by continuous glucose monitoring

    Baseline, 3 months, 6 months, 9 months, 12 months

  • Change in time under 70 mg/dL as measured by continuous glucose monitoring

    Baseline, 3 months, 6 months, 9 months, 12 months

  • Change in time over 250 mg/dL as measured by continuous glucose monitoring

    Baseline, 3 months, 6 months, 9 months, 12 months

  • Change in continuous glucose monitor wear time as measured by continuous glucose monitoring

    Baseline, 3 months, 6 months, 9 months, 12 months

  • Change in time in automated mode as measured by automated insulin delivery system

    Baseline, 3 months, 6 months, 9 months, 12 months

  • +13 more secondary outcomes

Other Outcomes (2)

  • Number of meetings with community health worker

    Up to 6 months

  • Duration in hours/minutes of meetings with community health worker

    Up to 6 months

Study Arms (1)

Community Health Worker

EXPERIMENTAL

Community Health Workers will meet with families monthly in the role of a diabetes technology coach, with additional visits as needed.

Other: Community Health Worker

Interventions

Community Health Worker will meet with families monthly (and more often as needed) in the role of a diabetes technology coach

Community Health Worker

Eligibility Criteria

Age5 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Self-reported as non-Hispanic Black
  • Clinical diagnosis of type 1 diabetes, requiring treatment with insulin at the time of consent
  • Currently using, or have used within the past 3 months, an automated insulin delivery system (consisting of a continuous glucose monitor and an insulin pump as well as an automated insulin delivery algorithm)
  • Clinical care provided at UH Cleveland Medical Center
  • Has not previously worked with a community health worker for help with diabetes technology

You may not qualify if:

  • Clinical diagnosis of Type 2 or monogenic diabetes
  • Completed high school
  • At least 1 parent/guardian or family support person not willing to participate
  • Non-English speaking guardians
  • Has not used automated insulin delivery within the past 3 months
  • Has previously worked with a CHW for help with diabetes technology
  • Custody of children and family services

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals Cleveland Medical Center

Cleveland, Ohio, 44106, United States

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Interventions

Community Health Workers

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Allied Health PersonnelHealth PersonnelHealth Care Facilities Workforce and Services

Study Officials

  • Sarah A MacLeish, DO

    University Hospitals Cleveland Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Wendy Campbell, RN, CDCES

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: Single arm pilot intervention study with use of historic controls
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Pediatrics

Study Record Dates

First Submitted

August 26, 2025

First Posted

September 4, 2025

Study Start

November 6, 2025

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

December 4, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

This is a pilot study

Locations